vTv Therapeutics
VTVT
VTVT
19 hedge funds and large institutions have $1.04M invested in vTv Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$181K |
| 2 |
VF
Virtu Financial
New York
|
+$73.7K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
+$39K |
| 4 |
Goldman Sachs
New York
|
+$17K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$2K |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$379K |
| 2 |
D.E. Shaw & Co
New York
|
-$71.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$38K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$18.3K |
| 5 |
Morgan Stanley
New York
|
-$13.9K |
